Balaxi Pharmaceuticals Limited

Balaxi Pharmaceuticals submitted its mandatory Business Responsibility and Sustainability Report for FY 2025-26 to the National Stock Exchange. The company reported 100% of its turnover from internati

Balaxi Pharmaceuticals will hold its 83rd Annual General Meeting on August 24, 2026, via video conference to adopt FY26 financial statements. Shareholders will vote on re-appointing Mrs. Minoshi Mahes